Published in J Chem Phys on August 14, 2013
Designing inhibitors of anthrax toxin. Expert Opin Drug Discov (2014) 0.80
Channel-forming bacterial toxins in biosensing and macromolecule delivery. Toxins (Basel) (2014) 0.77
Placement of oppositely charged aminoacids at a polypeptide termini determines the voltage-controlled braking of polymer transport through nanometer-scale pores. Sci Rep (2015) 0.76
Impact of Dendrimer Terminal Group Chemistry on Blockage of the Anthrax Toxin Channel: A Single Molecule Study. Toxins (Basel) (2016) 0.75
Biochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins. Membranes (Basel) (2016) 0.75
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Characterization of individual polynucleotide molecules using a membrane channel. Proc Natl Acad Sci U S A (1996) 18.77
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Physics of chemoreception. Biophys J (1977) 15.69
Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc Natl Acad Sci U S A (1972) 13.97
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A (1982) 10.36
Identification of the cellular receptor for anthrax toxin. Nature (2001) 8.78
Translocation of proteins into mitochondria. Annu Rev Biochem (2007) 7.53
Protein import into mitochondria. Annu Rev Biochem (1997) 6.82
Crystal structure of the anthrax toxin protective antigen. Nature (1997) 6.63
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A (2003) 5.95
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem (1986) 5.86
Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem (2007) 5.38
Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci U S A (1992) 4.91
Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem (1992) 4.87
The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol (2001) 4.57
A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore. Science (2005) 4.10
Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol (2003) 3.97
Driven polymer translocation through a narrow pore. Biophys J (1999) 3.84
Tom40 forms the hydrophilic channel of the mitochondrial import pore for preproteins [see comment]. Nature (1998) 3.77
Crystal structure of the anthrax lethal factor. Nature (2001) 3.75
Mitochondrial protein import. Biochim Biophys Acta (1989) 3.66
Mitochondrial Hsp70/MIM44 complex facilitates protein import. Nature (1994) 3.08
In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine (2001) 3.03
Endosomal escape pathways for delivery of biologicals. J Control Release (2010) 2.90
Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient. J Mol Biol (2005) 2.69
Designing a polyvalent inhibitor of anthrax toxin. Nat Biotechnol (2001) 2.67
The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch Pathol Lab Med (1998) 2.58
Reversible electrical breakdown of lipid bilayer membranes: a charge-pulse relaxation study. J Membr Biol (1979) 2.52
Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin. J Mol Biol (2004) 2.35
Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J Cell Biol (2004) 2.31
Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest (1995) 2.28
Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel. Proc Natl Acad Sci U S A (2004) 2.23
Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta (2006) 1.93
Lipid bilayer formation by contacting monolayers in a microfluidic device for membrane protein analysis. Anal Chem (2006) 1.93
Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase. Gene (1988) 1.90
Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A (1992) 1.87
Protein translocation through anthrax toxin channels formed in planar lipid bilayers. Biophys J (2004) 1.87
Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A (2005) 1.83
pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol Microbiol (1993) 1.81
Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. Mol Biol Cell (2004) 1.77
Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem (1999) 1.76
Nanoscopic porous sensors. Annu Rev Anal Chem (Palo Alto Calif) (2008) 1.73
Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun (1990) 1.72
Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol (1992) 1.70
Voltage-dependent block of anthrax toxin channels in planar phospholipid bilayer membranes by symmetric tetraalkylammonium ions. Effects on macroscopic conductance. J Gen Physiol (1990) 1.68
Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers. Nat Struct Mol Biol (2010) 1.62
A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry (2000) 1.61
Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry (1997) 1.56
Chloride concentration in endosomes measured using a ratioable fluorescent Cl- indicator: evidence for chloride accumulation during acidification. J Biol Chem (2001) 1.53
Cell killing by lysosomotropic detergents. J Cell Biol (1983) 1.51
Voltage-dependent pore formation and antimicrobial activity by alamethicin and analogues. J Membr Biol (2001) 1.47
Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev (2007) 1.47
The chloroplast protein import channel Toc75: pore properties and interaction with transit peptides. Biophys J (2002) 1.43
Membrane translocation by anthrax toxin. Mol Aspects Med (2009) 1.42
Effect of voltage on pores in membranes. Phys Rev A Gen Phys (1987) 1.40
Ratcheting up protein translocation with anthrax toxin. Protein Sci (2012) 1.38
Anthrax capsule vaccine protects against experimental infection. Vaccine (2004) 1.38
Anthrax biosensor, protective antigen ion channel asymmetric blockade. J Biol Chem (2005) 1.37
Automated formation of lipid-bilayer membranes in a microfluidic device. Nano Lett (2006) 1.37
Kinetics of pore size during irreversible electrical breakdown of lipid bilayer membranes. Biophys J (1993) 1.36
Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma. J Mol Biol (2010) 1.36
Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins. Nat Biotechnol (2006) 1.32
Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. Bioessays (2011) 1.30
Theoretical considerations on the role of membrane potential in the regulation of endosomal pH. Biophys J (1997) 1.29
Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Cell Mol Life Sci (2005) 1.29
Three-dimensional model of the pore form of anthrax protective antigen. Structure and biological implications. J Biomol Struct Dyn (2004) 1.29
Passive entry of a DNA molecule into a small pore. Proc Natl Acad Sci U S A (1999) 1.27
Anthrax toxin protective antigen: inhibition of channel function by chloroquine and related compounds and study of binding kinetics using the current noise analysis. Biophys J (2004) 1.20
Evidence for a proton-protein symport mechanism in the anthrax toxin channel. J Gen Physiol (2009) 1.20
Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem (2005) 1.17
Detergent-like action of the antibiotic peptide surfactin on lipid membranes. Biophys J (2001) 1.16
Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol Microbiol (2006) 1.16
Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci U S A (2003) 1.13
A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor. ACS Chem Biol (2010) 1.12
Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci U S A (2010) 1.11
Diffusion limitation in the block by symmetric tetraalkylammonium ions of anthrax toxin channels in planar phospholipid bilayer membranes. J Gen Physiol (1990) 1.10
Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjug Chem (1998) 1.10
Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect Immun (2006) 1.09
Recombinant polymer-protein fusion: a promising approach towards efficient and targeted gene delivery. J Gene Med (2006) 1.09
Conductance and ion selectivity of a mesoscopic protein nanopore probed with cysteine scanning mutagenesis. Biophys J (2005) 1.09
Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect Immun (2008) 1.08
Characterization of poly-gamma-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-gamma-glutamate. Appl Environ Microbiol (2003) 1.08
Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjug Chem (2008) 1.07
Planar bilayer membranes made from phospholipid monolayers form by a thinning process. Biophys J (1988) 1.05
Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell Microbiol (2000) 1.04
Thirty years of protein translocation into mitochondria: unexpectedly complex and still puzzling. Biochim Biophys Acta (2008) 1.04
Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism. PLoS One (2010) 1.03
Trapping a translocating protein within the anthrax toxin channel: implications for the secondary structure of permeating proteins. J Gen Physiol (2011) 1.01
Chemical dissection of protein translocation through the anthrax toxin pore. Angew Chem Int Ed Engl (2011) 1.01
Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J Pept Sci (2008) 1.00
A pathway of protein translocation in mitochondria mediated by the AAA-ATPase Bcs1. Mol Cell (2011) 1.00
Charge requirements for proton gradient-driven translocation of anthrax toxin. J Biol Chem (2011) 1.00
Effects of introducing a single charged residue into the phenylalanine clamp of multimeric anthrax protective antigen. J Biol Chem (2010) 0.96
Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling. Proc Natl Acad Sci U S A (2011) 0.94
Polymer translocation through a cylindrical channel. J Chem Phys (2008) 0.93
Imaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimeras. Cell Microbiol (2010) 0.93
Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob Agents Chemother (2006) 0.92
Energetics of protein translocation into mitochondria. Biochim Biophys Acta (2008) 0.92
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell (2008) 6.37
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog (2011) 3.26
Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med (2010) 3.25
Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis (2003) 3.15
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J Infect Dis (2007) 2.68
Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror (2011) 2.62
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35
In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A (2003) 2.32
Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A (2003) 2.18
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog (2006) 2.01
Single-molecule mass spectrometry in solution using a solitary nanopore. Proc Natl Acad Sci U S A (2007) 2.01
Identification of small molecule inhibitors of anthrax lethal factor. Nat Struct Mol Biol (2003) 1.86
Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis (2005) 1.82
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach. J Med Chem (2005) 1.80
The evolving field of biodefence: therapeutic developments and diagnostics. Nat Rev Drug Discov (2005) 1.79
Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol (2005) 1.78
Nanoscopic porous sensors. Annu Rev Anal Chem (Palo Alto Calif) (2008) 1.73
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J Immunol (2005) 1.69
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. Antimicrob Agents Chemother (2009) 1.66
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Development and characterization of a mouse model for Marburg hemorrhagic fever. J Virol (2009) 1.62
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol Med Microbiol (2004) 1.58
Molecular-scale structural and functional characterization of sparsely tethered bilayer lipid membranes. Biointerphases (2007) 1.54
3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A (2010) 1.52
P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem (2002) 1.48
Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol (2010) 1.48
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons. J Biol Chem (2006) 1.47
Theory for polymer analysis using nanopore-based single-molecule mass spectrometry. Proc Natl Acad Sci U S A (2010) 1.46
Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis (2004) 1.44
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine (2005) 1.44
Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin. Mol Pharmacol (2006) 1.42
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol (2013) 1.39
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One (2013) 1.38
Anthrax biosensor, protective antigen ion channel asymmetric blockade. J Biol Chem (2005) 1.37
Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochem Biophys Res Commun (2003) 1.34
Disease detection and management via single nanopore-based sensors. Chem Rev (2012) 1.32
Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol J (2007) 1.30
Enzyme activity to augment the characterization of tethered bilayer membranes. J Phys Chem B (2006) 1.29
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One (2012) 1.28
Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin Immunol (2003) 1.27
Structure of functional Staphylococcus aureus alpha-hemolysin channels in tethered bilayer lipid membranes. Biophys J (2009) 1.27
Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrob Agents Chemother (2009) 1.26
Assembly of a functional Machupo virus polymerase complex. Proc Natl Acad Sci U S A (2010) 1.24
Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses (2012) 1.23
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines (2008) 1.23
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology (2010) 1.23
Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol Pharmacol (2002) 1.20
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection. Vaccine (2004) 1.19
Interactions of halichondrin B and eribulin with tubulin. J Chem Inf Model (2011) 1.19
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates. Antimicrob Agents Chemother (2010) 1.18
Association of ebola virus matrix protein VP40 with microtubules. J Virol (2005) 1.18
Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem (2005) 1.17
Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis (2002) 1.17
PEG-labeled nucleotides and nanopore detection for single molecule DNA sequencing by synthesis. Sci Rep (2012) 1.16
Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding. Bioorg Med Chem (2005) 1.16
Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol Methods (2005) 1.16
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
Identification of a small-molecule entry inhibitor for filoviruses. J Virol (2011) 1.14
Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent. J Infect Dis (2007) 1.13
Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology (2004) 1.13
Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents. J Infect Dis (2007) 1.13
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease. J Med Chem (2007) 1.12